KRYS vs VRTX: Which Stock is Better?
Side-by-side comparison of Krystal Biotech Inc and Vertex Pharmaceuticals Inc in 2026
KRYS
Krystal Biotech Inc
$270.00
VRTX
Vertex Pharmaceuticals Inc
$444.28
Key Metrics Comparison
| Metric | KRYS | VRTX | Winner |
|---|---|---|---|
| Market Cap | $7.87B | $111.93B | VRTX |
| P/E Ratio | 39.04 | 28.74 | VRTX |
| EPS (TTM) | $6.85 | $15.31 | VRTX |
| Revenue Growth | 0.2% | 0.1% | KRYS |
| Gross Margin | 94.1% | 53.7% | KRYS |
Analyze KRYS
Full quant analysis
Analyze VRTX
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KRYS or VRTX a better investment?
Comparing KRYS and VRTX: Krystal Biotech Inc has a market cap of $7.87B while Vertex Pharmaceuticals Inc has $111.93B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KRYS and VRTX?
KRYS (Krystal Biotech Inc) and VRTX (Vertex Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KRYS or VRTX?
Based on P/E ratios, VRTX trades at a lower multiple (28.7x vs 39.0x).
Which is growing faster: KRYS or VRTX?
KRYS has higher revenue growth at 0.2% vs 0.1% for VRTX.
Which company is more profitable: KRYS or VRTX?
Krystal Biotech Inc (KRYS) has higher gross margins at 94.1% compared to 53.7% for VRTX.
Which is the larger company: KRYS or VRTX?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $111.93B compared to $7.87B for KRYS.
Should I buy KRYS or VRTX in 2026?
Both KRYS and VRTX have investment merit. KRYS trades at $270.00 while VRTX trades at $444.28. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KRYS and VRTX stock?
Key differences: Market Cap ($7.87B vs $111.93B), P/E Ratio (39.0x vs 28.7x), Revenue Growth (0.2% vs 0.1%), Gross Margin (94.1% vs 53.7%).